Phoenix Life Sciences International Limited
PLSI · OTC
2/28/2019 | 2/28/2018 | 2/28/2017 | 2/29/2016 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $18 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $6 |
| Gross Profit | $0 | $0 | $0 | $12 |
| % Margin | – | – | – | 67.8% |
| R&D Expenses | $0 | $0 | $0 | $121 |
| G&A Expenses | $2,437 | $0 | $36 | $371 |
| SG&A Expenses | $2,561 | $0 | $36 | $379 |
| Sales & Mktg Exp. | $124 | $0 | $0 | $15 |
| Other Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Expenses | $3,062 | $0 | $36 | $510 |
| Operating Income | -$3,062 | -$0 | -$36 | -$497 |
| % Margin | – | – | – | -2,700.8% |
| Other Income/Exp. Net | -$55 | -$76 | -$219 | -$291 |
| Pre-Tax Income | -$3,117 | -$77 | -$255 | -$788 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,117 | -$77 | -$255 | -$788 |
| % Margin | – | – | – | -4,279.3% |
| EPS | -89.11 | -2.46 | -8.63 | -28.81 |
| % Growth | -3,522.4% | 71.5% | 70% | – |
| EPS Diluted | -89.11 | -2.46 | -8.63 | -28.81 |
| Weighted Avg Shares Out | 35 | 31 | 30 | 27 |
| Weighted Avg Shares Out Dil | 35 | 31 | 30 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $4 |
| Interest Expense | $49 | $83 | $139 | $184 |
| Depreciation & Amortization | $1 | $161 | $53 | $10 |
| EBITDA | -$3,061 | -$0 | -$36 | -$355 |
| % Margin | – | – | – | -1,930.7% |